Telling patients they have Alzheimer's disease: Important for planning their future, and no evidence of ill effects

BMJ

Volumn 314, Issue 7077, 1997, Pages 321-

  Meyers, Barnett S ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; TACRINE;

ALZHEIMER DISEASE; DEMENTIA; DISEASE SEVERITY; DOCTOR PATIENT RELATION; EDITORIAL; HUMAN; MEDICAL ETHICS; PATIENT RIGHT; PRIORITY JOURNAL; PSYCHIATRIST; RELATIVE;

AUTONOMY; CLINICAL APPROACH/SOURCE; COMPETENCE; FAMILY MEMBERS; MENTAL HEALTH THERAPIES; PROFESSIONAL PATIENT RELATIONSHIP; RISKS AND BENEFITS; STIGMATIZATION;

ALZHEIMER DISEASE; DEMENTIA; HUMANS; PERSONAL AUTONOMY; PHYSICIAN-PATIENT RELATIONS; RISK ASSESSMENT; TRUTH DISCLOSURE;

EID: 85008308525     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.314.7077.321     Document Type: Editorial

References (18)

1. Conor PM, Kirby M, Coen R, Coakley D, Lawlor BA, O'Neil D. Family members' attitudes toward telling the patient with Alzheimer's disease their diagnosis. BMJ 1996; 313: 529–30.
2. Barnes RC. Telling the diagnosis to patients with Alzheimer's disease: relatives should act as proxy for patient. BMJ 1997; 314: 375–376.
3. Rice K, Warner N. Breaking the bad news. What do psychiatrists tell patients with dementia about their illness? Int J Geriatr Psychiatry 1994; 9: 467–71.
4. Rice K, Warner N, Tye T, Bayer A. Telling the diagnosis to patients with Alzheimer's disease: geriatricians' and psychiatrists' practice differs. BMJ 1997; 314: 376.
5. Erde EL, Nadal EC, Scholl TO. On truth telling and the diagnosis of Alzheimer's disease. J Fam Pract 1988; 26: 401–406.
6. Department of Health. The patient's charter. London: DoH, 1992.
7. President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. Summing up: final report on studies of the ethical and legal problems in medicine and biomedical research, March 1983. Washington, DC: Government Printing Office, 1983: 65–81.
8. Gillon R. Telling the truth and medical ethics. BMJ 1985; 291: 1556–1557.
9. Drickamer MA, Lachs MS. Should patients with Alzheimer's disease be told their diagnosis? N Engl J Med 1992; 326: 947–50.
10. Reifler BV, Larson E, Hanley R. Coexistence of cognitive impairment and depression in geriatric outpatients. Am J Psychiatry 1982; 139: 623–626.
11. Alexopoulos GS, Meyers BS, Young RC, Mattis S, Kakuma T. The course of geriatric depression with reversible dementia: a controlled study. Am J Psychiatry 1992: 159; 1693–1699.
12. Bahro M, Silber E, Sunderland R. How do patients with Alzheimer's disease cope with illness? A clinical experience report. J Am Geriatr Soc 1995; 43: 41–46.
13. Michen A, Deweer B, Pitlon B, Agid Y, Dubois B. Relation of anosognosia to frontal lobe dysfunction in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1994; 57: 805–809.
14. Kukull WA, Larson EB, Reifler BV, Lampe TH, Yerby MS, Hughes JP. The validity of 3 clinical diagnostic criteria for Alzheimer's disease. Neurology 1990; 40: 1364–1369.
15. Fitten LJ, Perryman KM, Wilkinson CJ, Little RJ, Burns MM, Pachana N, et al. Alzheimer's disease and vascular dementias and driving: a prospective road and laboratory study. JAMA 1995; 273: 1360–1365.
16. Eagger SA, Levy R, Sahakian BJ. Tacrine in Alzheimer's disease. Lancet 1991; 337: 989–92.
17. Mechcatie E. New Alzheimer's drug delays sentence. Clinical Psychiatric News 1997; 25: 28.
18. Ross J. Rules over research on mental patients invalid. New York Law Journal 1996 Dec 10:25–30.